Approval · Notice of Compliance 2774 · 1998
PMS-CAPTOPRIL: Notice of Compliance 2774
Issued June 17, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2774
- Date
- June 17, 1998
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Angiotensin-converting enzyme inhibitor
- Canadian reference product
- CAPOTEN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-CAPTOPRIL | 02230203 | Cancelled Post Market |
| PMS-CAPTOPRIL | 02230204 | Cancelled Post Market |
| PMS-CAPTOPRIL | 02230205 | Cancelled Post Market |
| PMS-CAPTOPRIL | 02230206 | Cancelled Post Market |